AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3%
Fri, 6 Nov

AJANTA PHARMA has announced its results for the quarter ended September 2020. Here is a detailed performance review of the same:

AJANTA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-19*
3
Jun-20*
3
Sep-20*
QoQ ChangeYoY Change
Net SalesRs m6,4286,6827,1597.1%11.4%
Other incomeRs m13213149-63.0%-63.3%
TurnoverRs m6,5606,8137,2085.8%9.9%
ExpensesRs m4,6514,4504,417-0.7%-5.0%
Gross profitRs m1,7662,2322,74322.9%55.3%
DepreciationRs m2332802831.1%21.6%
InterestRs m491615-6.1%-69.0%
Profit before taxRs m1,6162,0672,49220.6%54.3%
TaxRs m45258979034.1%74.8%
Profit after taxRs m1,1641,4781,70215.2%46.3%
Gross profit margin%27.533.438.3
Effective tax rate%28.028.531.7
Net profit margin%17.721.723.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 11.4% on a year-on-year (YoY) basis. The expenses were down by 5.0% YoY during the same period.
  • The company's operating profit increased by 55.3% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 38.3% in 2QFY21 as against 27.5% in 2QFY20.
  • Depreciation charges increased by 21.6% and finance costs declined by 69.0% YoY, respectively.
  • Other income declined by 63.3% YoY during the quarter.
  • Net profit for the quarter increased by 46.3% YoY. Net profit margins during the quarter increased from 17.7% in 2QFY20 to 23.6% in 2QFY21.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 7.1% on a quarter-on-quarter (QoQ) basis. The expenses were down by 0.7% QoQ during the same period.
  • The company's operating profit increased by 22.9% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 38.3% in 2QFY21 as against 33.4% in 1QFY20.
  • Net profit for the quarter increased by 15.2% QoQ, while net profit margins increased from 21.7% in 1QFY20 to 23.6% in 2QFY21.

To see how AJANTA PHARMA has performed over the last eight quarters,please visit here.

AJANTA PHARMA Share Price Performance

Over the last one year, AJANTA PHARMA share price has moved up from Rs 1,008.5 to Rs 1,607.4, registering a Gain of Rs 598.9 or around 59.4%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 19,704.0 (down 0.4%). Over the last one year it has moved up from 13,231.2 to 19,704.0, a gain of 6,473 points (up 48.9%).

Overall, the S&P BSE SENSEX is up 3.6% over the year.

Current Valuations

At the current price of Rs 1,607.4, the price to earnings (P/E) ratio of AJANTA PHARMA stands at 25.5 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 6.3 times.

Equitymaster requests your view! Post a comment on "AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3%". Click here!

  

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Feb 26, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS